GRIN2B Gene Early Infantile Epileptic Encephalopathy Type 27 NGS Genetic DNA Test
The GRIN2B Gene Early Infantile Epileptic Encephalopathy Type 27 NGS Genetic DNA Test is an advanced diagnostic tool that plays a significant role in identifying genetic mutations associated with early infantile epileptic encephalopathy (EIEE). This condition can severely affect the development and quality of life of infants, making early diagnosis and intervention crucial.
Importance of the Test
Understanding the genetic basis of neurological disorders is essential for effective management. The GRIN2B gene is known to be linked with various neurological disorders, and this test utilizes Next Generation Sequencing (NGS) technology to provide accurate results.
What the Test Measures
This genetic test measures the presence of mutations in the GRIN2B gene, which can lead to early infantile epileptic encephalopathy. By analyzing the genetic material, healthcare providers can identify specific mutations that may be responsible for the condition.
Who Should Consider This Test?
Parents and guardians of infants showing symptoms such as:
- Recurrent seizures
- Developmental delays
- Abnormal muscle tone
- Unexplained neurological symptoms
should consider this test. Additionally, those with a family history of neurological disorders may benefit from genetic counseling and testing.
Benefits of Taking the Test
- Early diagnosis and intervention can significantly improve outcomes.
- Helps in understanding the genetic risks and implications for family members.
- Guides treatment options and management strategies for affected individuals.
- Provides valuable information for future family planning.
Understanding Your Results
Results from the GRIN2B Gene test will indicate the presence or absence of mutations in the gene. A positive result may lead to further genetic counseling and management options, while a negative result can provide reassurance and help in ruling out genetic causes.
Test Information and Pricing
| Test Name | Discount Price | Regular Price |
|---|---|---|
| GRIN2B Gene Early Infantile Epileptic Encephalopathy Type 27 NGS Genetic DNA Test | 400,000 NGN | 560,000 NGN |
Turnaround Time: 3 to 4 Weeks
Sample Type: Blood or Extracted DNA or One drop Blood on FTA Card
Pre-Test Instructions: A clinical history of the patient is required, along with a genetic counseling session to draw a pedigree chart of family members affected with GRIN2B Gene Early Infantile Epileptic Encephalopathy Type 27.
Book Your Test Today!
To gain valuable insights into your child’s health, book the GRIN2B Gene Early Infantile Epileptic Encephalopathy Type 27 NGS Genetic DNA Test today! For inquiries or to schedule your appointment, please call or WhatsApp us at +2348077798758.
